NCT02846779View on ClinicalTrials.gov

Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes

NACompletedINTERVENTIONAL
Enrollment

6,000

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 30, 2017

Study Completion Date

February 10, 2018

Conditions
Diabetes
Interventions
OTHER

Low intensity

Low intensity telepharmacy outreach

OTHER

Moderate intensity

Moderate intensity telepharmacy outreach

OTHER

High intensity

High intensity telepharmacy outreach

Trial Locations (1)

07105-2200

Horizon Blue Cross Blue Shield of New Jersey, Newark

All Listed Sponsors
collaborator

Horizon Blue Cross Blue Shield of New Jersey

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT02846779 - Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes | Biotech Hunter | Biotech Hunter